| Cash Flow | 2025-06-30 |
|---|---|
| Stock compensation expense | 4,643,142 |
| Net (loss) income | 346,850 |
| Other current assets | -707,257 |
| Operating lease liabilities | -198,901 |
| Inventory | 453,997 |
| Deferred revenue | -2,690,893 |
| Product deposit | 210,237 |
| Accrued expenses | -5,865,264 |
| Accounts receivable | -887,684 |
| Accounts payable | 8,283,386 |
| Depreciation of fixed assets | 346,822 |
| Amortization of capitalized software | 4,627,520 |
| Amortization of intangibles | 505,888 |
| Amortization of debt discount | 200,888 |
| Accretion of consideration payable | 0 |
| Noncash operating lease expense | 577,689 |
| Net cash provided by operating activities | 11,707,834 |
| Cash paid for capitalized software costs | 5,648,965 |
| Purchase of equipment | 917,956 |
| Purchase of intangible assets | 0 |
| Net cash used in investing activities | -6,566,921 |
| Repayment of notes payable, net of prepayment penalty | 0 |
| Repayment of debt instruments | 2,052,288 |
| Cash proceeds from exercise of options | 0 |
| Distributions to non-controlling interest | 312,119 |
| Preferred stock dividends | 1,553,125 |
| Contingent consideration payments for resumebuild acquisition | 0 |
| Net cash used in financing activities | -3,917,532 |
| Net increase in cash | 1,223,381 |
LifeMD, Inc. (LFMD)
LifeMD, Inc. (LFMD)